Electronic data capture for clinical trials is a multi-billion-dollar industry (1) that has brought demonstrable benefits to all phases of clinical research. Still, the portion of clinical trials collecting and managing their data on paper is too large to ignore. As recently as 2015, Open Health News reported that less than half of all new clinical trials were using EDC. And while researchers continue to sift through file cabinets and manila folders, the eClinical industry is roaring forward with cutting-edge refinements and developments like eSource, randomization, RBM, and more. With EDC creating new potential for shorter timelines, budget savings, and easier data management every year, why do so many clinical trials still limit themselves to paper-based data capture?